Telemedicine in Qualifying Care Transition Between Tertiary and Primary Health Care Among Stable Coronary Artery Disease Patients: a Randomized Non-inferiority Trial
试验速览
- 阶段
- 不适用
- 入组人数
- 264
- 试验地点
- 2
- 主要终点
- Number of participants that stay in Canadian Cardiovascular Society (CCS) Functional Classification of Angina I and II as a measure of safety
研究概览
简要总结
The purpose of this study is to determine whether the telemedicine use in primary health care is effective in the accompaniment of stable coronary artery disease patients who were discharged from the tertiary health care clinics.
详细描述
This study is a randomized non-inferiority trial for patients with chronic coronary artery disease from a tertiary hospital with outpatient discharge criteria. The purpose is to compare the use of telemedicine in the quality of care transition between tertiary care and primary care patients (intervention group), with patients who remain in the outpatient clinic of a tertiary hospital (control group).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •individuals with diagnosis of Coronary Artery Disease (CAD) in Canadian Cardiovascular Society (CCS)'s functional classification of angina Class I or II
- •patients who did not submit hospitalization for cardiovascular disease in the last year
排除标准
- •patients who were not followed up in the health service to at least one year
- •unstable patients requiring adjustments of medications or who are performing some diagnostic evaluation at discharge outpatient
结局指标
主要结局
Number of participants that stay in Canadian Cardiovascular Society (CCS) Functional Classification of Angina I and II as a measure of safety
时间窗: within one year after discharge
Not evolve into a higher class than the measure before the intervention
次要结局
- diabetes control(within one year after discharge)
- Number of participants with instability of the disease(within one year after discharge)
- blood pressure control(within one year after discharge)
- dyslipidemia control(within one year after discharge)